Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Test and Treat for Targeted Elimination of Lymphatic Filariasis in Ghana and Tanzania
PACTR202409873380150Phase 3Not yet recruiting
- Sponsor
- Kumasi Centre for Collaborative Research in Tropical Medicine
- Start
- Oct 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label trial of doxycycline and moxidectin in filariasis (3 arms), sponsored by Kumasi Centre for Collaborative Research in Tropical Medicine. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
doxycyclinemoxidectin
03
Conditions
filariasis
Beyond the preview
Go deeper on PACTR202409873380150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409873380150.